Skip to search.
 BSE Down 0.07% NSE Down 0.02%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
10.77 Down 0.84(7.24%) 1:30AM
|After Hours : 10.70 Down 0.07 (0.65%) 5:27AM
Add to Portfolio
Prev Close:11.61
Open:11.52
Bid:10.70 x 400
Ask:11.25 x 1000
1y Target Est:16.67
Beta:0.49
Earnings Date:6 May - 11 May (Est.)
Day's Range:10.72 - 11.61
52wk Range:2.31 - 14.40
Volume:6,246,223
Avg Vol (3m):4,990,090
Market Cap:1.12B
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 7.24%1.12B
IMGNUp 5.05%770.66M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):882.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Mar-15) :-0.13
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing cancer therapies. The company is employing novel gene expression, and control and cells technologies to deliver cell-based therapies for the tr... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback